What is Neuraceq®
A PET Scan with Neuraceq® gives physicians a “window into the brain.”
A PET Scan with Neuraceq® gives physicians a “window into the brain.”
A memory or thinking test can tell a doctor if you have cognitive impairment. However, it cannot tell your doctor the cause of the problem.
An image of the brain, or a “scan,” gives your doctor a minimally invasive way to look inside the brain to see what might be causing memory and thinking problems.
The most common cause of cognitive impairment due to a neurodegenerative disease is Alzheimer’s disease (AD). In AD, sticky clumps of protein called beta(β)‐amyloid plaques build up in the brain, affecting the way the brain works.
Neuraceq® is a radioactive tracer designed to stick to β-amyloid neuritic plaques in the brain for a short time. When used with PET scanning to create an image of your brain, Neuraceq® can reveal the presence or absence of β-amyloid plaque.
Neuraceq® has been well-studied
Neuraceq® was studied in a large clinical trial program for this type of agent. This program was approved by the Food and Drug Administration (FDA) and European Medicines Agency (EMA).
